Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Small-Sample-Size Clinical Study to Evaluate the Effectiveness and Safety of the Gastric Bypass Stent System in Treatment of Patients With Nonalcoholic Fatty Liver Disease.

NCT05495139 is registered in ClinicalTrials.gov with Hangzhou Tangji Medical Technology Co., Ltd. as lead sponsor.

NCT NCT05495139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Small-Sample-Size Clinical Study to Evaluate the Effectiveness and Safety of the Gastric Bypass Stent System in Treatment of Patients With Nonalcoholic Fatty Liver Disease.
Lead sponsor
Hangzhou Tangji Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2022
Completion date
June 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver disease